Abstract
Background: Helicteres hirsuta has been used traditionally as a useful agent for hepatoprotective treatment. The aim of the current study is to isolate chemical constituents from the EtOAc extract of H. hirsuta stem and evaluate the capacity of the isolated compounds against hydroperoxide damaged rat liver cells.
Methods: Column chromatography was used for phytochemical isolation whereas MTT method was applied for intracellular antioxidative assay.
Results: Phytochemical analysis of the EtOAc extract of H. hirsuta stem led to the isolation and determination of four triterpenoids betulin (1), bentulinic acid (2), alphitolic acid (3), and oleanolic acid (4), together with two steroids stigmast-4-ene-6β-ol-3-one (5), and β-sitostenone (6), whereas EtOAc extract of its leaf was composed of three steroids cucurbitacin D (11), cucurbitacin I (12), and simiarenol (13), four flavonoids tiliroside (14), potengriffioside A (15), kaempferide (16), and isokaempferide (17), along with two carotenoids lutelin (18), and β-carotene (19). Isolated compounds 3, 5, 6, 16, and 17 were found in genus Helicteres for the first time, while carotenoids 18, and 19 were never isolated from family Sterculiaceae before. Phytochemicals derived H. hirsuta species are also useful agents for antioxidative drugs, e.g, flavonol 17 induced the significant EC50 value of 22.24 ± 0.14 μg/mL, as compared with that of positive control curcumin (EC50 19.33 ± 0.77 μg/mL), against hydroperoxide damaged rat liver cells.
Conclusion: Antioxidative activity of the EtOAc extract of H. hirsuta stem against hydroperoxide is mostly based on the role of flavonoids.
Keywords: Helicteres hirsuta, stem, leaf, phytochemistry, antioxidation, flavonoids, hydroperoxide.
Graphical Abstract
The Natural Products Journal
Title:Antioxidant Constituents from the Stem and Leaf of Helicteres hirsuta Loureiro
Volume: 11 Issue: 5
Author(s): Nguyen Thanh Tra, Ba Thi Cham, Nguyen Thi Thu Ha, Le Thi Tu Anh, Nguyen Van Tuyen and Ninh The Son*
Affiliation:
- Department of Applied Biotechnology, Institute of Chemistry, Vietnam Academy of Science and Technology (VAST), Cau Giay, Hanoi,Vietnam
Keywords: Helicteres hirsuta, stem, leaf, phytochemistry, antioxidation, flavonoids, hydroperoxide.
Abstract:
Background: Helicteres hirsuta has been used traditionally as a useful agent for hepatoprotective treatment. The aim of the current study is to isolate chemical constituents from the EtOAc extract of H. hirsuta stem and evaluate the capacity of the isolated compounds against hydroperoxide damaged rat liver cells.
Methods: Column chromatography was used for phytochemical isolation whereas MTT method was applied for intracellular antioxidative assay.
Results: Phytochemical analysis of the EtOAc extract of H. hirsuta stem led to the isolation and determination of four triterpenoids betulin (1), bentulinic acid (2), alphitolic acid (3), and oleanolic acid (4), together with two steroids stigmast-4-ene-6β-ol-3-one (5), and β-sitostenone (6), whereas EtOAc extract of its leaf was composed of three steroids cucurbitacin D (11), cucurbitacin I (12), and simiarenol (13), four flavonoids tiliroside (14), potengriffioside A (15), kaempferide (16), and isokaempferide (17), along with two carotenoids lutelin (18), and β-carotene (19). Isolated compounds 3, 5, 6, 16, and 17 were found in genus Helicteres for the first time, while carotenoids 18, and 19 were never isolated from family Sterculiaceae before. Phytochemicals derived H. hirsuta species are also useful agents for antioxidative drugs, e.g, flavonol 17 induced the significant EC50 value of 22.24 ± 0.14 μg/mL, as compared with that of positive control curcumin (EC50 19.33 ± 0.77 μg/mL), against hydroperoxide damaged rat liver cells.
Conclusion: Antioxidative activity of the EtOAc extract of H. hirsuta stem against hydroperoxide is mostly based on the role of flavonoids.
Export Options
About this article
Cite this article as:
Tra Thanh Nguyen, Cham Thi Ba , Ha Thi Thu Nguyen , Anh Thi Tu Le , Tuyen Van Nguyen and Son The Ninh *, Antioxidant Constituents from the Stem and Leaf of Helicteres hirsuta Loureiro, The Natural Products Journal 2021; 11 (5) . https://dx.doi.org/10.2174/2210315510999200728131328
DOI https://dx.doi.org/10.2174/2210315510999200728131328 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy
Current Pharmaceutical Design Chiral Separation of Several Flavanones by Liquid Chromatography
Current Pharmaceutical Analysis Network-QSAR with Reaction Poset Quantitative Superstructure-Activity Relationships (QSSAR) for PCB Chromatographic Properties
Current Bioinformatics Aptamers in Drug Design: An Emerging Weapon to Fight a Losing Battle
Current Drug Targets Inhibition of NADPH: Quinone Oxidoreductase Activity of Camel Lens ζ-Crystallin by Colchicine
Current Enzyme Inhibition Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
Current Pharmaceutical Design Predicting Antibacterial Peptides by the Concept of Chou’s Pseudo-amino Acid Composition and Machine Learning Methods
Protein & Peptide Letters ToF/RGB Sensor Fusion for 3-D Endoscopy
Current Medical Imaging The Assessment and Characterisation of Drug Plasma Protein Binding in the Body Using QSAR
Mini-Reviews in Medicinal Chemistry The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Options for the Management of Aromatase Inhibitor- Associated Bone Loss
Endocrine, Metabolic & Immune Disorders - Drug Targets Development and Validation of a Highly Sensitive HPLC Method for Determination of Paclitaxel in Pharmaceutical Dosage forms and Biological Samples
Current Pharmaceutical Analysis Use of Virostatics as a Means of Targeting Human Immunodeficiency Virus Infection
Current Pharmaceutical Design Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Current Strategies for the Treatment of Ulcerative Colitis
Recent Patents on Inflammation & Allergy Drug Discovery Predicting Citrullination Sites in Protein Sequences Using mRMR Method and Random Forest Algorithm
Combinatorial Chemistry & High Throughput Screening Urokinase-a Very Popular Cardiovascular Agent
Recent Patents on Cardiovascular Drug Discovery Anti-Cancer, Pharmacokinetic and Biodistribution Studies of Cremophor EL Free Alternative Paclitaxel Formulation
Current Drug Safety Presystemic Metabolism of Orally Administered Peptide Drugs and Strategies to Overcome It
Current Drug Metabolism